Shares of several biotech companies moved higher following quarterly financial results, clinical trial developments and business updates. Genmab reported positive Phase 3 results for its cancer drug combination, Pulmonx posted improved quarterly results, Axogen and OrthoPediatrics reported revenue growth, and Replimune reported a narrower quarterly loss.